131 related articles for article (PubMed ID: 31276400)
1. Time-Domain Analysis of Molecular Dynamics Trajectories Using Deep Neural Networks: Application to Activity Ranking of Tankyrase Inhibitors.
Berishvili VP; Perkin VO; Voronkov AE; Radchenko EV; Syed R; Venkata Ramana Reddy C; Pillay V; Kumar P; Choonara YE; Kamal A; Palyulin VA
J Chem Inf Model; 2019 Aug; 59(8):3519-3532. PubMed ID: 31276400
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel Tankyrase Inhibitors through Molecular Docking-Based Virtual Screening and Molecular Dynamics Simulation Studies.
Berishvili VP; Kuimov AN; Voronkov AE; Radchenko EV; Kumar P; Choonara YE; Pillay V; Kamal A; Palyulin VA
Molecules; 2020 Jul; 25(14):. PubMed ID: 32664504
[TBL] [Abstract][Full Text] [Related]
3. Predicting the impacts of mutations on protein-ligand binding affinity based on molecular dynamics simulations and machine learning methods.
Wang DD; Ou-Yang L; Xie H; Zhu M; Yan H
Comput Struct Biotechnol J; 2020; 18():439-454. PubMed ID: 32153730
[TBL] [Abstract][Full Text] [Related]
4. Machine learning in computational docking.
Khamis MA; Gomaa W; Ahmed WF
Artif Intell Med; 2015 Mar; 63(3):135-52. PubMed ID: 25724101
[TBL] [Abstract][Full Text] [Related]
5.
Loganathan L; Muthusamy K; Jayaraj JM; Kajamaideen A; Balthasar JJ
J Biomol Struct Dyn; 2019 Sep; 37(14):3637-3648. PubMed ID: 30204055
[TBL] [Abstract][Full Text] [Related]
6. Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors.
Hua Z; Bregman H; Buchanan JL; Chakka N; Guzman-Perez A; Gunaydin H; Huang X; Gu Y; Berry V; Liu J; Teffera Y; Huang L; Egge B; Emkey R; Mullady EL; Schneider S; Andrews PS; Acquaviva L; Dovey J; Mishra A; Newcomb J; Saffran D; Serafino R; Strathdee CA; Turci SM; Stanton M; Wilson C; Dimauro EF
J Med Chem; 2013 Dec; 56(24):10003-15. PubMed ID: 24294969
[TBL] [Abstract][Full Text] [Related]
7. Protein secondary structure prediction improved by recurrent neural networks integrated with two-dimensional convolutional neural networks.
Guo Y; Wang B; Li W; Yang B
J Bioinform Comput Biol; 2018 Oct; 16(5):1850021. PubMed ID: 30419785
[TBL] [Abstract][Full Text] [Related]
8. K
Jiménez J; Škalič M; Martínez-Rosell G; De Fabritiis G
J Chem Inf Model; 2018 Feb; 58(2):287-296. PubMed ID: 29309725
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent and selective nonplanar tankyrase inhibiting nicotinamide mimics.
Nkizinkiko Y; Suneel Kumar BVS; Jeankumar VU; Haikarainen T; Koivunen J; Madhuri C; Yogeeswari P; Venkannagari H; Obaji E; Pihlajaniemi T; Sriram D; Lehtiö L
Bioorg Med Chem; 2015 Aug; 23(15):4139-4149. PubMed ID: 26183543
[TBL] [Abstract][Full Text] [Related]
10. Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set.
Sun H; Li Y; Tian S; Xu L; Hou T
Phys Chem Chem Phys; 2014 Aug; 16(31):16719-29. PubMed ID: 24999761
[TBL] [Abstract][Full Text] [Related]
11. RosENet: Improving Binding Affinity Prediction by Leveraging Molecular Mechanics Energies with an Ensemble of 3D Convolutional Neural Networks.
Hassan-Harrirou H; Zhang C; Lemmin T
J Chem Inf Model; 2020 Jun; 60(6):2791-2802. PubMed ID: 32392050
[TBL] [Abstract][Full Text] [Related]
12. Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors.
Thorsell AG; Ekblad T; Karlberg T; Löw M; Pinto AF; Trésaugues L; Moche M; Cohen MS; Schüler H
J Med Chem; 2017 Feb; 60(4):1262-1271. PubMed ID: 28001384
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
[TBL] [Abstract][Full Text] [Related]
14. Boosted neural networks scoring functions for accurate ligand docking and ranking.
Ashtawy HM; Mahapatra NR
J Bioinform Comput Biol; 2018 Apr; 16(2):1850004. PubMed ID: 29495922
[TBL] [Abstract][Full Text] [Related]
15. Sighting of tankyrase inhibitors by structure- and ligand-based screening and in vitro approach.
Kirubakaran P; Arunkumar P; Premkumar K; Muthusamy K
Mol Biosyst; 2014 Oct; 10(10):2699-712. PubMed ID: 25091558
[TBL] [Abstract][Full Text] [Related]
16. Zoning in on Tankyrases: A Brief Review on the Past, Present and Prospective Studies.
Peters XQ; Malinga TH; Agoni C; Olotu FA; Soliman MES
Anticancer Agents Med Chem; 2019; 19(16):1920-1934. PubMed ID: 31648650
[TBL] [Abstract][Full Text] [Related]
17.
Liu J; Feng K; Ren Y
J Biomol Struct Dyn; 2019 Sep; 37(14):3803-3821. PubMed ID: 30261821
[TBL] [Abstract][Full Text] [Related]
18. Tankyrase inhibitors as therapeutic targets for cancer.
Kamal A; Riyaz S; Srivastava AK; Rahim A
Curr Top Med Chem; 2014; 14(17):1967-76. PubMed ID: 25262803
[TBL] [Abstract][Full Text] [Related]
19. Tankyrase 1 Inhibitors with Drug-like Properties Identified by Screening a DNA-Encoded Chemical Library.
Samain F; Ekblad T; Mikutis G; Zhong N; Zimmermann M; Nauer A; Bajic D; Decurtins W; Scheuermann J; Brown PJ; Hall J; Gräslund S; Schüler H; Neri D; Franzini RM
J Med Chem; 2015 Jun; 58(12):5143-9. PubMed ID: 26061013
[TBL] [Abstract][Full Text] [Related]
20. Scaffold hopping approach on the route to selective tankyrase inhibitors.
Liscio P; Carotti A; Asciutti S; Ferri M; Pires MM; Valloscuro S; Ziff J; Clark NR; Macchiarulo A; Aaronson SA; Pellicciari R; Camaioni E
Eur J Med Chem; 2014 Nov; 87():611-23. PubMed ID: 25299683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
